Charles Schwab’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
+175,070
| New | +$259K | ﹤0.01% | 3345 |
|
|
2024
Q2 | – | Sell |
-153,561
| Closed | -$193K | – | 3666 |
|
|
2024
Q1 | $193K | Hold |
153,561
| – | – | ﹤0.01% | 3242 |
|
|
2023
Q4 | $273K | Hold |
153,561
| – | – | ﹤0.01% | 3231 |
|
|
2023
Q3 | $255K | Buy |
153,561
+25,143
| +20% | +$41.7K | ﹤0.01% | 3242 |
|
|
2023
Q2 | $257K | Buy |
+128,418
| New | +$257K | ﹤0.01% | 3266 |
|